Efficacy of Q-switched Nd:YAG Laser 1,064nm for the treatment of melasma

Ireej Ehsan, Shahbaz Aman, Muhammad Nadeem, Atif Kazmi

Abstract


Objective To evaluate the efficacy of Q-Switched Nd:YAG laser 1,064nm for the treatment of  melasma.

 

Methods A total of 100 patients were included in this study. Treatment area was cleansed and Q-Switched Nd:YAG laser 1,064nm, was delivered with settings of 3mm spot size, energy fluence ranging from 500-700 joules and repeated frequency at 6 Hz. Clinical response was assessed by MASI score.

 

Results A total of 100 patients were included in the study. Mean age of the patients was 31.18±5.51 years. There were 13 males (13%) and 87 females (87%). Mean duration of disease was 1.99±0.88 years. Type of melasma was as follows: epidermal 47 (47%), dermal 31 (31%) and mixed 22 (22%). Q-Switched Nd:YAG laser 1,064nm for the treatment of  melasma was effective in 59 patients (59%).

 

Conclusion 1064nm Nd:YAG laser was safe, effective and well-tolerated by all patients.

 


Keywords


Melasma, Q-Switched Nd:YAG Laser 1,064nm, efficacy

Full Text:

PDF

References


Sarkar R, Bansal S, Garg VK. Chemical peels for melasma in dark skinned patients. J Cutan and Asthet Surg 2012; 5:247-53.

Grimes P, Watson J. Treating epidermal melasma with 4% hydroquinone skin care system plus tretinoin cream 0.025%. Cutis 2013; 91: 47-54.

Gulzar K, Mujtaba G, Hameed S. Comparison between efficacy of serial glycolic acid peel and triple combination creams vs. triple combination cream alone in treatment of melasma. J Pak Assoc Dermatol 2010; 20: 84-8.

Sarkar R, Chugh S, Garg VK. Newer and upcoming therapies for melasma. Indian J Dermatol Venerol Leprol 2012; 78: 417-28.

Ethawi AMD, Sidiq LM. Comparison of the effect of salicylic acid chemical peel combined with topical modified Kilgman formula and topical modified Kilgman formula alone in the treatment of melasma. The Iraqi Postgrad Med J 2011; 10: 191-7.

Puri N. Comparative study of 15% TCA peel versus 35% glycolic acid peel for the treatment of melasma. Indian Dermatol J Online 2012; 3: 109-13.

Ali R, Aman S, Nadeem M, Kazmi AH. Quality of life in patients of melasma. J Pak Assoc Dermatol 2013; 23: 143-8.

Bevec T. Treating melasma with Sub-Thermolytic Q-Switched Nd:YAG. J LA & HA 2011; 1: 53-5.

Jeong SY, Shin JB, Yeo UC, Kim WS, Kim IH. Low-fluence Q-Switched Nd:YAG laser for melasma with pre or post-treatment triple combination cream. Dermatol Surg 2010; 36: 909-18.

Chan NPY, Ho SGY, Shek SYN, Yeung CK, Chan HH. A case series of facial depigmentation associated with low fluence Q-Switched 1,064nm Nd:YAG laser for skin rejuvenation and melasma. Lasers Surg Med 2010; 42: 712-9.

Kauvar AN. Successful treatment of melasma using a combination of microdermabrasion and Q-switched Nd:YAG lasers. Lasers Surg Med 2012; 44: 117-24.

XI Z, Gold M H, Zhong L, Ying L. Efficacy and safety of Q-switched Nd:YAG laser treatment of melasma. Dermatologic Surgery 2011; 37: 962-70.

Sim J H, Park Y L, Lee J S, Lee S Y et al. Treatment of melasma by low flue Burns T, Breathnach S, Cox N, Griffiths C. Rook’s textbook of dermatology. 8th ed. Wiley-Blackwell: 2010. P.78.1-78.5.

Sim J H, Park Y L, Lee J S, Lee S Y et al. Treatment of melasma by low fluence 1,064nm Q-Switched Nd:YAG laser. J Dermatolog Treat 2014; 25: 212-7.

Kamal T, Iftikhar U. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1064nm) laser for the treatment of facial melasma in local population. J Pak Assoc Dermatol 2017; 27(2): 164-168.


Refbacks

  • There are currently no refbacks.


ISSN: 1560-9014